<qa>  What is the funding source for this trial?This study is a Phase 3, multicenter, non-randomized study to evaluate the safety and efficacy of the next-generation outpatient Magnetic Mini-Mover Procedure 3MP in 15 patients aged 8-14 years for the correction of pectus excavatum sunken chest. 3MP for pectus excavatum uses a magnetically coupled implant to pull the sternum forward and gradually remodel the deformed costal cartilage. The Funding Source for this trial is the FDA Office of Orphan Products Development Grant R01 FD003341. 